Rogerio Vivaldi Coelho's Insider Trades & SAST Disclosures
Rogerio Vivaldi Coelho's most recent trade in Viatris Inc was a trade of 23,660 Restricted Stock Units done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rogerio Vivaldi Coelho.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viatris Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris Inc | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 21,267 | 21,267 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 21,267 | 0 | - | - | Restricted Stock Units | |
| Viatris Inc | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 424 | 21,691 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 423 | 0 | - | - | Dividend Equivalent Units | |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 3,400 | 14,400 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 21,267 | 21,267 | - | - | Restricted Stock Units | |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 6,000 | 11,000 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Purchase of securities on an exchange or from another person at price $ 22.06 per share. | 08 Jun 2023 | 5,000 | 5,000 (0%) | 0% | 22.1 | 110,300 | Common Stock |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 8,750 | 8,750 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges